Delivery Order SPE2DE22D0008-SPE2D625F0K66

Award Date 3/3/25
Potential Completion Date 3/6/25
Potential Value $3.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to federal agencies. The contract, valued at $2,326.05, is for the supply of ALBACLONE Anti-S (Big S) products. The contract is a firm fixed-price delivery order with a period of performance running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned for-profit organization, for the provision of ALBACLONE ANTI-A medical supplies. The contract has a ceiling value of $1,123.00 and a period of performance through April 4, 2024. It is a firm fixed price contract, and there was no set-aside designation used. Alba Bioscience, Inc. is a leading provider of specialized in vitro diagnostics and blood bank reagents, and this...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and quality control materials to various U.S. government agencies. The contract, valued at $22,621.60, is a delivery order for "ALBACLONE ANTI-D BLEND" products. It is a firm fixed-price contract with a period of performance ending on...
This federal contract award, valued at $7,900.00, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and quality control materials to various U.S. government agencies. The award, classified as a Delivery Order under a Firm Fixed Price contract, is for the supply of ALBACLONE Anti-C (Big C) products. The contract has no set-aside designation and has an ultimate...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned for-profit organization registered in SAM.gov. The contract is for the supply of Albacyte Antibody Screen (3-Cell) medical testing kits, with a ceiling value of $1,906.00 and a period of performance through May 22, 2024. The contract has no set-aside designation. Alba Bioscience, Inc. is a subsidiary of Quotient Biodiagnostics, Inc., a leading provider of specialized in vitro...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned for-profit organization, for the supply of an ALBASURE quality control kit product. The contract has a firm fixed price of $2,281.00 and a period of performance through June 18, 2024. Alba Bioscience is a leading provider of specialized blood banking products and services, primarily supporting federal agencies such as the Department of Veterans Affairs (VA), DLA, and the...
This federal contract award, with ID SPE2DE22D0008|SPE2D625F1414, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, and quality control materials. The contract, with a ceiling value of $1,118.00, is for the delivery of "ALBACLONE ANTI-A" products, which are likely blood typing reagents or antibodies used in blood banking operations. The contract is a Delivery...
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking products. The contract, worth $1,740.00, is a delivery order under contract SPE2DE22D0008|SPE2D625F15SJ, awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain. The contract is for the supply of ALBACYTE Antibody ID Panels, which are specialized 16-cell panels used for antibody identification in blood banking operations. This contract does...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The $1,118.00 Firm Fixed Price Delivery Order (SPE2DE22D0008|SPE2D625F38A1) is for the product "ALBACLONE ANTI-A" and has an ultimate completion date of December...
This federal contract award was made by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, valued at $2,370.00, is for the delivery of ALBACLONE anti-B products. The award is not associated with a set-aside program and is a Firm Fixed Price Delivery Order contract type. Alba...
  • SPE2DE22D0008
    Indefinite Delivery Contract
  • SPE2DE22D0008-SPE2D625F0K66
    Delivery Order

This is a delivery order contract awarded to Alba Bioscience, Inc., a for-profit organization that specializes in in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, worth $3,546.10, is for the supply of ALBACLONE Anti-S (Big S) products to the Defense Logistics Agency (DLA) Medical Supply Chain, a defense agency. The contract has a firm-fixed-price pricing type and a completion date of March 6, 2025. It is not designated as a set-aside contract. Alba Bioscience, Inc. is a subsidiary of Quotient Biodiagnostics, Inc. and has been awarded numerous federal contracts, primarily from the DLA and the Department of Veterans Affairs, to provide specialized blood banking products to support diagnostic testing, blood typing, and transfusion services for federal healthcare facilities.

Generated 6/2/25, 9:52 AM